99 related articles for article (PubMed ID: 6613093)
1. [Long-term persistence of the vaccinia virus in a child with a congenital skin disease].
Gurvich EB; Gomes LA; Grigor'eva LV; Dzagurov SG; Vilesova IS
Vopr Virusol; 1983; (3):348-51. PubMed ID: 6613093
[TBL] [Abstract][Full Text] [Related]
2. Vaccinia virus persistence in a child against the background of immune deficiency.
Gurvich EB; Gomes LA; Yartsev MN; Khakhalin LN; Grigor'eva LB; Dmitrieva NG; Polunin AI
J Hyg Epidemiol Microbiol Immunol; 1986; 30(2):177-83. PubMed ID: 3722811
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of the degree of specific humoral immunity, content of serum immunoglobulins and isolation of vaccinia virus in children with post-vaccinal encephalitis after smallpox vaccination.
Gurvich EB
J Hyg Epidemiol Microbiol Immunol; 1981; 25(3):311-20. PubMed ID: 6117594
[TBL] [Abstract][Full Text] [Related]
4. [Results of a study of the pathogenesis of postvaccinal encephalitis].
Dzagurov SG; Gurvich EB; Ozeretskovskiĭ NA
Vopr Virusol; 1981; (4):398-404. PubMed ID: 6117985
[TBL] [Abstract][Full Text] [Related]
5. Determination of immunity to vaccinia virus by using diluted inactivated vaccinia vaccine solution for skin testing.
Somekh E; Smetana Z; Tanay A; Dalal I; Babai I; Mendelson E
Vaccine; 2004 Dec; 23(3):321-4. PubMed ID: 15530675
[TBL] [Abstract][Full Text] [Related]
6. Smallpox vaccination and adverse reactions. Guidance for clinicians.
Cono J; Casey CG; Bell DM;
MMWR Recomm Rep; 2003 Feb; 52(RR-4):1-28. PubMed ID: 12617510
[TBL] [Abstract][Full Text] [Related]
7. The persistence of humoral and cellular immunities more than three decades after smallpox vaccination.
Kim SH; Yeo SG; Park KH; Bang JW; Kim HB; Kim NJ; Jee Y; Cho H; Oh MD; Choe KW
Clin Microbiol Infect; 2007 Jan; 13(1):91-3. PubMed ID: 17184294
[TBL] [Abstract][Full Text] [Related]
8. Persisting humoral antiviral immunity within the Japanese population after the discontinuation in 1976 of routine smallpox vaccinations.
Hatakeyama S; Moriya K; Saijo M; Morisawa Y; Kurane I; Koike K; Kimura S; Morikawa S
Clin Diagn Lab Immunol; 2005 Apr; 12(4):520-4. PubMed ID: 15817760
[TBL] [Abstract][Full Text] [Related]
9. Clinical responses to smallpox vaccine in vaccinia-naive and previously vaccinated populations: undiluted and diluted Lancy-Vaxina vaccine in a single-blind, randomized, prospective trial.
Kim SH; Yeo SG; Jang HC; Park WB; Lee CS; Lee KD; Kim HB; Kim NJ; Kim YT; Jee Y; Cho H; Oh MD; Choe KW
J Infect Dis; 2005 Sep; 192(6):1066-70. PubMed ID: 16107961
[TBL] [Abstract][Full Text] [Related]
10. Serological Immunity to Smallpox in New South Wales, Australia.
Costantino V; Trent MJ; Sullivan JS; Kunasekaran MP; Gray R; MacIntyre R
Viruses; 2020 May; 12(5):. PubMed ID: 32443405
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of modified vaccinia virus Ankara as an alternative vaccine against smallpox in chronically HIV type 1-infected individuals undergoing HAART.
Cosma A; Nagaraj R; Staib C; Diemer C; Wopfner F; Schätzl H; Busch DH; Sutter G; Goebel FD; Erfle V
AIDS Res Hum Retroviruses; 2007 Jun; 23(6):782-93. PubMed ID: 17604541
[TBL] [Abstract][Full Text] [Related]
12. Smallpox vaccine, ACAM2000: Sites and duration of viral shedding and effect of povidone iodine on scarification site shedding and immune response.
Pittman PR; Garman PM; Kim SH; Schmader TJ; Nieding WJ; Pike JG; Knight R; Johnston SC; Huggins JW; Kortepeter MG; Korman L; Ranadive M; Quinn X; Meyers MS
Vaccine; 2015 Jun; 33(26):2990-6. PubMed ID: 25930115
[TBL] [Abstract][Full Text] [Related]
13. Persistence of vaccinia at the site of smallpox vaccination.
Cummings JF; Polhemus ME; Hawkes C; Klote M; Ludwig GV; Wortmann G
Clin Infect Dis; 2008 Jan; 46(1):101-2. PubMed ID: 18171221
[TBL] [Abstract][Full Text] [Related]
14. Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
Wharton M; Strikas RA; Harpaz R; Rotz LD; Schwartz B; Casey CG; Pearson ML; Anderson LJ; ;
MMWR Recomm Rep; 2003 Apr; 52(RR-7):1-16. PubMed ID: 12710832
[TBL] [Abstract][Full Text] [Related]
15. Lack of vaccinia viremia after smallpox vaccination.
Cummings JF; Polhemus ME; Hawkes C; Klote M; Ludwig GV; Wortmann G
Clin Infect Dis; 2004 Feb; 38(3):456-8. PubMed ID: 14727224
[TBL] [Abstract][Full Text] [Related]
16. Activity of vaccinia virus-neutralizing antibody in the sera of smallpox vaccinees.
Viner KM; Isaacs SN
Microbes Infect; 2005 Apr; 7(4):579-83. PubMed ID: 15848274
[TBL] [Abstract][Full Text] [Related]
17. Immune responses to vaccinia and influenza elicited during primary versus recent or distant secondary smallpox vaccination of adults.
Treanor J; Wu H; Liang H; Topham DJ
Vaccine; 2006 Nov; 24(47-48):6913-23. PubMed ID: 17014939
[TBL] [Abstract][Full Text] [Related]
18. Isolation of vaccinia virus from the pharynx of children vaccinated against smallpox.
Gurvich EB; Braginskaya VP; Shenkman LS; Sokolova AF; Davydova AV
J Hyg Epidemiol Microbiol Immunol; 1974; 18(1):69-76. PubMed ID: 4473485
[No Abstract] [Full Text] [Related]
19. Response to smallpox vaccine in persons immunized in the distant past.
Frey SE; Newman FK; Yan L; Lottenbach KR; Belshe RB
JAMA; 2003 Jun; 289(24):3295-9. PubMed ID: 12824212
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax in healthy vaccinia-naive adults.
Frey SE; Newman FK; Kennedy JS; Ennis F; Abate G; Hoft DF; Monath TP
Vaccine; 2009 Mar; 27(10):1637-44. PubMed ID: 19071184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
